Leukemia inhibitory factor promotes castration-resistant prostate cancer and neuroendocrine differentiation by activated ZBTB46

PURPOSE: The molecular targets for castration-resistant prostate cancer (CRPC) are unknown because the disease inevitably recurs, and therapeutic approaches for CRPC patients remain less well understood. We sought to investigate regulatory mechanisms that result in increased therapeutic resistance,...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Cancer Res
Main Authors: Liu, Yen-Nien, Niu, Shaoxi, Chen, Wei-Yu, Zhang, Qingfu, Tao, Yulei, Chen, Wei-Hao, Jiang, Kuo-Ching, Chen, Xufeng, Shi, Huaiyin, Liu, Aijun, Li, Jinhang, Li, Yanjing, Lee, Yi-Chao, Zhang, Xu, Huang, Jiaoti
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7168873/
https://ncbi.nlm.nih.gov/pubmed/30962287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3239
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍